Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Authors:
- Jack CuzickJCJack Cuzick
- Marc ArbynMAMarc Arbyn
- Rengaswamy SankaranarayananRSRengaswamy Sankaranarayanan
- Vivien TsuVTVivien Tsu
- Guglielmo RoncoGRGuglielmo Ronco
- Marie-Helene MayrandMMMarie-Helene Mayrand
- Joakim DillnerJDJoakim Dillner
- Chris J.L.M. MeijerCMChris J.L.M. Meijer
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Liquid Compared With Conventional Cervical CytologyObstetrics & Gynecology, 2008
- Mass screening programmes and trends in cervical cancer in Finland and the NetherlandsInternational Journal of Cancer, 2007
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- Cost-Effectiveness of Cervical-Cancer Screening in Five Developing CountriesNew England Journal of Medicine, 2005
- Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screeningBritish Journal of Cancer, 2005
- Effective cervical cytology screening programmes in middle-income countries: The Chilean experienceCancer Detection Prevention, 2005
- Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial NeoplasiaJNCI: Journal of the National Cancer Institute, 2004
- Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort modelBMJ, 1999
- Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancerBritish Journal of Cancer, 1996
- Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.BMJ, 1986